In view of the uncertainty, this meta-analysis aims to synthesize existing evidence to clarify the role of PTX-3 in COPD and its exacerbations, providing a comprehensive assessment of its potential as a biomarker for disease severity and exacerbation status. Here, PTX3 is linked to chronic obstructive pulmonary disease.